PainChek Says Contracted Annual Recurring Revenue Rises 10% in June Quarter
MT Newswires Live
Jul 03
PainChek (ASX:PCK) said its contracted annual recurring revenue rose 10% to AU$5.4 million in the June quarter, according to a Thursday Australian bourse filing.
The company's net contracted licenses increased 9% to 110,000 over the period, while the net license retention rate came in at 106%, the filing said.
The company attributed the rise in licenses and annual recurring revenue to its expansion strategies and new customer acquisitions, including in the UK, Australia, and Canada.
PainChek's shares were down almost 5% at market close Thursday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.